Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:19 p.m.

    📋 G1 THERAPEUTICS, INC. (GTHX) - Financial Results

    Filing Date: 2022-08-03

    Accepted: 2022-08-03 06:35:46

    Event Type: Financial Results

    Event Details:

    G1 Therapeutics Inc (GTHX) Reports Q3 2022 Financial Results G1 Therapeutics Inc (GTHX) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 10573
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: $143,957
      • expected in the second half of 2023
      • expected in the first quarter of 2023
      • expected in the fourth quarter of 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Selling General Administrative 25.24K 52.42K $-27.19K -51.86%
    Operating Expenses Loss From Operations -38.19K -83.74K $45.55K +54.39%
    Other Income Expense Interest Income 9.00 59.00 $-50.00 -84.75%
    Other Income Expense Interest Expense -927.00 -4.67K $3.75K +80.16%
    Other Income Expense Total Other Income Expense -1.01K -4.89K $3.88K +79.37%
    Other Income Expense Net Loss -39.42K -39.42K $0.00 +0.00%
    Other Income Expense Net Loss Per Share -0.94 -0.94 $0.00 +0.00%
    Revenue 4.07K 3.28K $795.00 +24.26%
    Selling, General & Administrative 25.24K 52.42K $-27.19K -51.86%
    Loss from Operations -38.19K -83.74K $45.55K +54.39%
    Interest Income 9.00 59.00 $-50.00 -84.75%
    Interest Expense -927.00 -4.67K $3.75K +80.16%
    Total Other Income/(Expense) -1.01K -4.89K $3.88K +79.37%
    Net Loss -39.42K -39.42K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: G1 Therapeutics Inc
    • CIK: 0001560241
    • Ticker Symbol: GTHX
    • Period End Date: 2022-08-03
    • Document Type: 8-K

Search

News categories